Prostate Cancer
Recent Abstracts
Active surveillance in prostate cancer: The need to standardize - Abstract
June 21, 2011
Old issues and new perspectives on prostate cancer hormonal therapy: The molecular substratum - Abstract
June 21, 2011
Patterns of information behavior and prostate cancer knowledge among African-American men - Abstract
June 21, 2011
Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients - Abstract
June 21, 2011
Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics - Abstract
June 21, 2011
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial
June 21, 2011
A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008 - Abstract
June 20, 2011
Pathology in prostate research: Optimizing the pathological data - Abstract
June 20, 2011
Tumour markers in prostate cancer III: Biomarkers in urine - Abstract
June 20, 2011
Updates on therapeutic targets and agents in castration-resistant prostate cancer - Abstract
June 20, 2011
Active surveillance for favorable risk prostate cancer: Rationale, results, and vis a vis focal therapy role - Abstract
June 20, 2011
TRP channels in prostate cancer: The good, the bad and the ugly? - Abstract
June 20, 2011
Image-guided, adaptive radiotherapy of prostate cancer: Toward new standards of radiotherapy practice - Abstract
June 20, 2011
Stereotactic body radiotherapy for prostate cancer: Current results of a phase II trial - Abstract
June 20, 2011
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: Potential of anti-IL-6 therapies - Abstract
June 20, 2011
Editor's Commentary - Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression
June 20, 2011
Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells - Abstract
June 19, 2011
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer - Abstract
June 17, 2011
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies - Abstract
June 17, 2011
Laparoendoscopic single site (LESS) radical prostatectomy: A review of the initial experience - Abstract
June 17, 2011
Page 1368 of 1420
Start
Prev
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free